LS Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Sell
770
-85
-10% -$29.1K 0.04% 117
2026
Q1
$301K Sell
855
-30
-3% -$10.7K 0.05% 114
2025
Q4
$290K Hold
885
0.04% 120
2025
Q3
$250K Buy
885
+35
+4% +$10.2K 0.04% 127
2025
Q2
$237K Sell
850
-2,851
-77% -$808K 0.03% 124
2025
Q1
$1.15M Sell
3,701
-687
-16% -$203K 0.18% 74
2024
Q4
$1.14M Buy
4,388
+660
+18% +$196K 0.17% 75
2024
Q3
$1.2M Sell
3,728
-652
-15% -$213K 0.18% 74
2024
Q2
$1.37M Buy
4,380
+105
+2% +$30.8K 0.21% 73
2024
Q1
$1.22M Buy
4,275
+140
+3% +$41K 0.19% 74
2023
Q4
$1.19M Sell
4,135
-115
-3% -$31.3K 0.21% 71
2023
Q3
$1.14M Buy
4,250
+575
+16% +$143K 0.21% 67
2023
Q2
$816K Buy
3,675
+2,720
+285% +$631K 0.14% 78
2023
Q1
$231K Buy
+955
New +$234K 0.04% 124
2021
Q4
Sell
-1,450
Closed -$308K 152
2021
Q3
$308K Sell
1,450
-50,460
-97% -$11.6M 0.04% 128
2021
Q2
$12.7M Sell
51,910
-18,751
-27% -$4.61M 1.6% 23
2021
Q1
$17.6M Sell
70,661
-3,882
-5% -$926K 0.98% 20
2020
Q4
$17.1M Buy
74,543
+349
+0.5% +$80.5K 0.9% 20
2020
Q3
$18.9M Sell
74,194
-2,179
-3% -$540K 1.07% 13
2020
Q2
$18M Sell
76,373
-78
-0.1% -$17.8K 1.12% 12
2020
Q1
$15.5M Sell
76,451
-1,469
-2% -$321K 1.12% 13
2019
Q4
$18.8M Sell
77,920
-960
-1% -$212K 1.01% 16
2019
Q3
$15.3M Sell
78,880
-550
-0.7% -$106K 0.89% 20
2019
Q2
$14.6M Sell
79,430
-617
-0.8% -$110K 0.88% 20
2019
Q1
$15.2M Sell
80,047
-1,489
-2% -$284K 0.95% 16
2018
Q4
$15.9M Sell
81,536
-5,790
-7% -$1.13M 1.11% 11
2018
Q3
$18.1M Sell
87,326
-1,910
-2% -$376K 1.04% 13
2018
Q2
$16.5M Sell
89,236
-6,469
-7% -$1.14M 0.99% 14
2018
Q1
$16.3M Sell
95,705
-1,849
-2% -$339K 0.97% 18
2017
Q4
$17M Sell
97,554
-1,492
-2% -$264K 0.99% 18
2017
Q3
$18.5M Sell
99,046
-2,332
-2% -$413K 1.1% 11
2017
Q2
$17.5M Buy
101,378
+1,368
+1% +$223K 1.07% 14
2017
Q1
$16.4M Sell
100,010
-346
-0.3% -$57.5K 1.05% 14
2016
Q4
$14.7M Buy
100,356
+403
+0.4% +$60.7K 1.03% 18
2016
Q3
$16.7M Sell
99,953
-204
-0.2% -$34.5K 1.23% 12
2016
Q2
$15.2M Sell
100,157
-364
-0.4% -$56.6K 1.05% 16
2016
Q1
$15.1M Buy
100,521
+1,168
+1% +$174K 1.12% 14
2015
Q4
$16.1M Buy
99,353
+3,030
+3% +$476K 1.25% 11
2015
Q3
$13.3M Sell
96,323
-3,339
-3% -$526K 1.07% 15
2015
Q2
$15.3M Sell
99,662
-2,252
-2% -$361K 1.14% 16
2015
Q1
$16.3M Sell
101,914
-1,075
-1% -$169K 1.24% 14
2014
Q4
$16.4M Buy
102,989
+12,678
+14% +$1.98M 1.33% 15
2014
Q3
$12.7M Buy
90,311
+78,440
+661% +$10.2M 1.09% 24
2014
Q2
$1.41M Buy
11,871
+278
+2% +$32.2K 0.12% 177
2014
Q1
$1.43M Sell
11,593
-322
-3% -$39.1K 0.12% 175
2013
Q4
$1.36M Buy
11,915
+4,498
+61% +$512K 0.12% 157
2013
Q3
$830K Buy
7,417
+1,148
+18% +$124K 0.1% 144
2013
Q2
$618K Buy
+6,269
New +$651K 0.08% 145

Other funds holding AMGN

LS Investment Advisors's AMGN Position: Q2 2026 in Review

LS Investment Advisors reduced its Amgen (AMGN) stake by 9.9% in Q2 2026, selling an estimated $29.1K and leaving 770 shares worth $279K. The position accounts for 0.04% of the portfolio, ranked #117.

LS Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 48 quarters since. The position peaked at $18.9M in Q3 2020. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • LS Investment Advisors held 770 shares of Amgen worth $279K as of Q2 2026.
  • LS Investment Advisors sold 85 Amgen shares in Q2 2026, an estimated $29.1K.
  • Amgen made up 0.04% of LS Investment Advisors's portfolio in Q2 2026, its #117 holding.
  • LS Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 48 quarters since.
  • LS Investment Advisors's Amgen position peaked at $18.9M in Q3 2020.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on LS Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.